Emami Ltd

Emami Ltd

₹ 446 1.42%
24 Apr - close price
About

Emami is engaged in manufacturing & marketing of personal care & healthcare products with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm and others.(Source : 201903 Annual Report Page No: 193)

Key Points

Leadership in Niche segments:[1] Emami is one of the leading companies in the personal and healthcare segment with leadership in the niche Ayurvedic segment. The Company has a portfolio of 450+ products based on ayurvedic formulations.

  • Market Cap 19,479 Cr.
  • Current Price 446
  • High / Low 589 / 360
  • Stock P/E 29.7
  • Book Value 53.8
  • Dividend Yield 1.79 %
  • ROCE 26.1 %
  • ROE 26.0 %
  • Face Value 1.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 31.1%
  • Company has been maintaining a healthy dividend payout of 59.3%

Cons

  • Stock is trading at 8.30 times its book value
  • The company has delivered a poor sales growth of 4.31% over past five years.
  • Tax rate seems low

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: FMCG Industry: Personal Care - Indian

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
845 648 608 712 875 672 688 685 836 698 698 701 813
523 496 446 448 553 524 535 502 563 552 524 494 530
Operating Profit 322 153 162 264 322 148 153 183 273 146 173 207 283
OPM % 38% 24% 27% 37% 37% 22% 22% 27% 33% 21% 25% 30% 35%
14 46 32 39 17 35 43 7 8 11 8 10 19
Interest 1 4 0 0 1 1 2 1 1 0 0 0 0
Depreciation 93 81 82 83 82 81 86 43 43 43 41 41 41
Profit before tax 242 114 113 220 255 100 109 147 238 113 139 176 261
Tax % 17% 20% 18% 17% 17% -262% 11% 2% 5% 4% 7% 7% 5%
202 91 93 182 211 364 97 144 225 109 129 164 249
EPS in Rs 4.55 2.05 2.09 4.10 4.75 8.26 2.19 3.26 5.09 2.46 2.94 3.75 5.71
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
1,312 1,531 1,595 1,904 2,150 2,302 2,354 2,489 2,390 2,582 2,867 2,907 2,910
1,042 1,182 1,167 1,393 1,495 1,562 1,654 1,782 1,798 1,738 1,970 2,129 2,101
Operating Profit 270 348 428 511 655 739 700 706 592 845 897 777 809
OPM % 21% 23% 27% 27% 30% 32% 30% 28% 25% 33% 31% 27% 28%
60 56 61 103 38 45 28 27 91 103 123 48 48
Interest 16 6 4 5 54 58 33 19 19 12 3 4 2
Depreciation 19 21 33 31 252 305 305 318 326 361 328 215 167
Profit before tax 296 377 452 577 387 422 389 396 338 574 689 606 689
Tax % 13% 14% 12% 18% 14% 18% 20% 23% 14% 17% -23% 5%
257 324 398 472 332 346 310 305 289 475 851 574 650
EPS in Rs 5.66 7.13 8.77 10.39 7.32 7.63 6.82 6.72 6.37 10.69 19.28 13.00 14.86
Dividend Payout % 47% 37% 40% 34% 48% 46% 51% 59% 63% 75% 41% 62%
Compounded Sales Growth
10 Years: 7%
5 Years: 4%
3 Years: 7%
TTM: 1%
Compounded Profit Growth
10 Years: 6%
5 Years: 9%
3 Years: 27%
TTM: -21%
Stock Price CAGR
10 Years: 7%
5 Years: 3%
3 Years: -4%
1 Year: 24%
Return on Equity
10 Years: 27%
5 Years: 24%
3 Years: 31%
Last Year: 26%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 15 15 23 23 23 23 23 45 45 44 44 44 44
Reserves 682 762 906 1,189 1,537 1,690 1,949 2,019 1,757 1,715 2,042 2,220 2,302
155 72 31 24 660 435 279 54 158 51 224 21 22
305 302 300 320 312 294 347 464 475 493 516 467 547
Total Liabilities 1,157 1,152 1,260 1,556 2,532 2,441 2,598 2,583 2,435 2,304 2,826 2,751 2,914
401 374 374 424 1,894 1,952 1,763 1,643 1,422 1,100 1,270 1,088 1,016
CWIP 66 44 8 25 60 20 30 36 8 6 3 2 1
Investments 81 164 296 502 95 128 315 187 161 264 361 392 538
610 570 582 605 482 340 489 716 844 934 1,192 1,270 1,359
Total Assets 1,157 1,152 1,260 1,556 2,532 2,441 2,598 2,583 2,435 2,304 2,826 2,751 2,914

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
337 327 378 497 534 715 577 513 546 878 596 731
-115 -119 -130 -217 -1,294 -261 -237 20 -251 -200 -188 -106
-154 -202 -264 -221 511 -519 -331 -434 -399 -679 -398 -612
Net Cash Flow 68 6 -15 59 -249 -64 9 99 -105 -0 10 13

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 22 19 17 11 9 5 11 21 28 14 25 33
Inventory Days 65 59 76 58 68 81 86 89 102 116 123 102
Days Payable 58 43 64 62 89 72 86 94 108 120 111 88
Cash Conversion Cycle 29 35 30 7 -12 15 11 16 22 10 37 47
Working Capital Days -12 -10 -1 -9 5 -39 18 20 36 10 35 44
ROCE % 35% 44% 51% 61% 29% 24% 23% 19% 17% 30% 31% 26%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
53.86% 53.86% 53.86% 54.27% 54.27% 54.27% 54.27% 54.27% 54.52% 54.84% 54.84% 54.84%
12.49% 12.71% 12.52% 12.72% 11.47% 11.25% 11.14% 11.01% 11.46% 11.90% 12.86% 13.46%
24.48% 24.17% 25.49% 24.32% 26.47% 27.02% 27.02% 26.92% 26.22% 25.21% 23.94% 22.06%
9.17% 9.26% 8.14% 8.69% 7.80% 7.47% 7.58% 7.81% 7.81% 8.05% 8.35% 9.63%
No. of Shareholders 81,50882,19383,25786,24289,97185,46090,28597,04389,95579,21682,15191,334

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls